Unknown

Dataset Information

0

PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.


ABSTRACT: Ewing sarcoma (ES) is the second most frequent bone cancer in childhood and is characterized by the presence of the balanced translocation t(11;22)(q24;q12) in more than 85% of cases, generating a dysregulated transcription factor EWS/FLI1. This fusion protein is an essential oncogenic component of ES development which is necessary for tumor cell maintenance and represents an attractive therapeutic target. To search for modulators of EWS/FLI1 activity we screened a library of 153 targeted compounds and identified inhibitors of the PI3K pathway to directly modulate EWS/FLI1 transcription. Surprisingly, treatment of four different ES cell lines with BEZ235 resulted in down regulation of EWS/FLI1 mRNA and protein by ~50% with subsequent modulation of target gene expression. Analysis of the EWS/FLI1 promoter region (-2239/+67) using various deletion constructs identified two 14 bp minimal elements as being important for EWS/FLI1 transcription. We identified SP1 as modulator of EWS/FLI1 gene expression and demonstrated direct binding to one of these regions in the EWS/FLI1 promoter by EMSA and ChIP experiments. These results provide the first insights on the transcriptional regulation of EWS/FLI1, an area that has not been investigated so far, and offer an additional molecular explanation for the known sensitivity of ES cell lines to PI3K inhibition.

SUBMITTER: Giorgi C 

PROVIDER: S-EPMC4745699 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.

Giorgi Chiara C   Boro Aleksandar A   Rechfeld Florian F   Lopez-Garcia Laura A LA   Gierisch Maria E ME   Schäfer Beat W BW   Niggli Felix K FK  

Oncotarget 20151001 30


Ewing sarcoma (ES) is the second most frequent bone cancer in childhood and is characterized by the presence of the balanced translocation t(11;22)(q24;q12) in more than 85% of cases, generating a dysregulated transcription factor EWS/FLI1. This fusion protein is an essential oncogenic component of ES development which is necessary for tumor cell maintenance and represents an attractive therapeutic target. To search for modulators of EWS/FLI1 activity we screened a library of 153 targeted compou  ...[more]

Similar Datasets

| S-EPMC9945741 | biostudies-literature
| S-EPMC3435532 | biostudies-literature
| S-EPMC2884367 | biostudies-literature
| S-EPMC6425124 | biostudies-literature
| S-EPMC2666556 | biostudies-literature
| S-EPMC3123042 | biostudies-literature
| S-EPMC4535656 | biostudies-literature
| S-EPMC2763206 | biostudies-literature
| S-EPMC4357724 | biostudies-literature
| S-EPMC6125457 | biostudies-literature